Live Breaking News & Updates on Howard hochster

Stay informed with the latest breaking news from Howard hochster on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Howard hochster and stay connected to the pulse of your community

Rutgers Research Summit Aims to Broaden Oncologic Perspectives Across New Jersey

Andrew Evens, DO, MBA, MSc, highlights key points presented during the 2023 Rutgers Cancer Institute of New Jersey’s Annual Oncology Clinical Practice and Research Summit, the clinical implications of these presentations, and lymphoma treatment innovations that Rutgers Cancer Institute is providing to patients throughout New Jersey.

Toms-river , New-jersey , United-states , Massachusetts , Jersey-city , Boston , New-brunswick , Long-branch , Newark-beth-israel-medical-center , Andrew-evens , Susan-parsons , Matthew-matasar

Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders

Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-jersey , United-states , United-kingdom , India , University-of-texas , Texas , New-delhi , Delhi , Yale-school , San-antonio , British , American

First patient dosed in study evaluating colon cancer drug

MEI Pharma has dosed the first patient in its phase 1 study evaluating ME-344 in combination with bevacizumab (AVASTIN) in patients with previously treated metastatic colorectal cancer.

United-states , Howard-hochster , Richard-ghalie , Rutgers-cancer-institute-metabolomics-center , Rutgers-cancer-institute , Academic-gi-cancer-consortium , Bio-developments , Ipelines , Ancer , Ncology , Linical-trial ,

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

MEI Pharma, Inc. , a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the dosing of the first patient in a Phase 1b study evaluating ME-344 in...
-Today at 08:05 am- MarketScreener

United-states , American , Richard-ghalie , Howard-hochster , Exchange-commission , American-society-of-clinical-oncology , Pharma-inc , Rutgers-cancer-institute , Nasdaq , Linkedin , American-cancer-society , Academic-gi-cancer-consortium

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVAST

SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the dosing of the first patient in a Phase 1b study evaluating ME-344 in combination with bevacizumab (AVASTIN®) in patients with previously treated meta...

United-states , American , Joele-frank , Richard-ghalie , Dan-katcher-aaron-palash , Davida-walsey , Howard-hochster , Wilkinson-brimmer-katcher , Linkedin , Rutgers-cancer-institute-metabolomics-center , American-cancer-society , American-society-of-clinical-oncology

Are Early-Onset Colorectal Cancers More Aggressive?

Comparative analysis looks at the characteristics of early- versus average-onset disease

New-york , United-states , Memorial-sloan-kettering-cancer-center , New-jersey , New-brunswick , Massachusetts , Howard-hochster , Mike-bassett , Andrea-cercek , Cathy-eng , Sloan-kettering , Vanderbilt-ingram-cancer-center